Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4+ T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication

被引:81
作者
Palmer, BE
Boritz, E
Blyveis, N
Wilson, CC
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Clin Immunol, Dept Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO 80262 USA
关键词
D O I
10.1128/JVI.76.12.5925-5936.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
One hallmark of uncontrolled, chronic human immunodeficiency virus type 1 (HIV-1) infection is the absence of strong HIV-1-specific, CD4(+) T-cell-proliferative responses, yet the mechanism underlying this T helper (Th)-cell defect remains controversial. To better understand the impact of HIV-1 replication on Th-cell function, we compared the frequency of CD4(+) Th-cell responses based on production of gamma interferon to lymphoproliferative responses directed against HIV-1 proteins in HIV-1-infected subjects with active in vivo viral replication versus those on suppressed highly active antiretroviral therapy (HAART). No statistically significant differences in the frequencies of cytokine-secreting, HIV-1-specific CD4(+) T cells between the donor groups were found, despite differences in viral load and treatment status. However, HIV-1-specific lymphoproliferative responses were significantly greater in the subjects with HAART suppression than in subjects with active viral replication. Similar levels of HIV-1 RNA were measured in T-cell cultures stimulated with HIV-1 antigens regardless of donor in vivo viral loads, but only HIV-1-specific CD4(+) T cells from subjects with HAART suppression proliferated in vitro, suggesting that HIV-1 replication in vitro does not preclude HIV-1-specific lymphoproliferation. This study demonstrates a discordance between the frequency and proliferative capacity of HIV-1-specific CD4(+) T cells in subjects with ongoing in vivo viral replication and suggests that in vivo HIV-1 replication contributes to the observed defect in HIV-1-specific CD4(+) T-cell proliferation.
引用
收藏
页码:5925 / 5936
页数:12
相关论文
共 42 条
[1]   Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease [J].
Al-Harthi, L ;
Siegel, J ;
Spritzler, J ;
Pottage, J ;
Agnoli, M ;
Landay, A .
AIDS, 2000, 14 (07) :761-770
[2]   Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir [J].
Angel, JB ;
Kumar, A ;
Parato, K ;
Filion, LG ;
Diaz-Mitoma, F ;
Daftarian, P ;
Pham, B ;
Sun, E ;
Leonard, JM ;
Cameron, DW .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) :898-904
[3]   Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression [J].
Angel, JB ;
Parato, KG ;
Kumar, A ;
Kravcik, S ;
Badley, AD ;
Fex, C ;
Ashby, D ;
Sun, E ;
Cameron, DW .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :546-554
[4]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[5]   ANTIGENIC PEPTIDES RECOGNIZED BY LYMPHOCYTES-T FROM AIDS VIRAL ENVELOPE-IMMUNE HUMANS [J].
BERZOFSKY, JA ;
BENSUSSAN, A ;
CEASE, KB ;
BOURGE, JF ;
CHEYNIER, R ;
LURHUMA, Z ;
SALAUN, JJ ;
GALLO, RC ;
SHEARER, GM ;
ZAGURY, D .
NATURE, 1988, 334 (6184) :706-708
[6]   Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution [J].
Blankson, JN ;
Gallant, JE ;
Siliciano, RF .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :657-661
[7]   CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infection [J].
Carlesimo, M ;
Pontesilli, O ;
Varani, AR ;
Bernardi, ML ;
Mazzone, AM ;
Rosso, R ;
Guerra, EC ;
Cassone, A ;
Paganelli, R ;
Aiuti, F .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (03) :406-411
[8]  
CHOREMIPAPADOPOULOU H, 1994, J ACQ IMMUN DEF SYND, V7, P245
[9]  
Chougnet C, 1998, EUR J IMMUNOL, V28, P646, DOI 10.1002/(SICI)1521-4141(199802)28:02<646::AID-IMMU646>3.0.CO
[10]  
2-6